Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Brasil Pharma.
R$0.62
2
+R$0
+0%
Tuesday 20:00
1D
1W
1M
3M
1Y
5Y
Add to Watchlist
Statistics
Day High
0.62
Day Low
0.62
52W High
0.62
52W Low
0.62
Volume
0
Avg. Volume
0
Mkt Cap
70.11M
P/E Ratio
0.06
Dividend Yield
-
Dividend
-
Dividends
0
%
Dividend Yield
Jun 12
R$0.01
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A
People Also Follow
This list is based on the watchlists of people on Stock Events who follow BPHA3.SA. It's not an investment recommendation.
Alphabet
78096
GOOGL
Apple
67979
AAPL
Microsoft
63406
MSFT
Amazon
59137
AMZN
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Raia Drogasil.
RADL3.SA
Mkt Cap
39.68B
Raia Drogasil is a major player in the Brazilian pharmaceutical retail sector, directly competing with Brasil Pharma in terms of market presence and product offerings.
Profarma Distribuidora De Produtos Farmaceuticos.
PFRM3.SA
Mkt Cap
416.88M
Profarma distributes pharmaceuticals, directly competing with Brasil Pharma in wholesale and retail distribution across similar regions.
Hypera.
HYPE3.SA
Mkt Cap
27.23B
Hypera Pharma is one of the largest pharmaceutical companies in Brazil, competing across several product lines that overlap with Brasil Pharma's offerings.
Diagnosticos da America
DASA3.SA
Mkt Cap
6.74B
Dasa is involved in the healthcare sector in Brazil, indirectly competing with Brasil Pharma through its extensive network of diagnostic centers and hospitals.
Fleury SA
FLRY3.SA
Mkt Cap
5.45B
Fleury operates in the medical diagnostics market in Brazil, competing indirectly with Brasil Pharma by providing health services and diagnostics, which are integral to healthcare.
Qualicorp Consultoria e Corretora de Seguros.
QUAL3.SA
Mkt Cap
1.65B
Qualicorp provides health plan management services in Brazil, indirectly competing with Brasil Pharma by influencing customer choices in healthcare services.
Odontoprev SA
ODPV3.SA
Mkt Cap
5.55B
Odontoprev is involved in dental care plans in Brazil, competing indirectly with Brasil Pharma in the broader healthcare market.
About
Show more...
CEO
ISIN
BRBPHAACNOR6
Listings
Add to Watchlist